Susquehanna International Group’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Hold |
0
| – | – | – | 6822 |
|
|
2023
Q1 | – | Sell |
-54,419
| Closed | -$49K | – | 7044 |
|
|
2022
Q4 | $49K | Buy |
54,419
+42,369
| +352% | +$38.1K | ﹤0.01% | 5169 |
|
|
2022
Q3 | $72K | Buy |
+12,050
| New | +$72K | ﹤0.01% | 5396 |
|
|
2022
Q2 | – | Sell |
-81,739
| Closed | -$311K | – | 6978 |
|
|
2022
Q1 | $311K | Sell |
81,739
-14,267
| -15% | -$54.3K | ﹤0.01% | 4310 |
|
|
2021
Q4 | $432K | Buy |
96,006
+38,771
| +68% | +$174K | ﹤0.01% | 4001 |
|
|
2021
Q3 | $267K | Buy |
57,235
+30,943
| +118% | +$144K | ﹤0.01% | 4410 |
|
|
2021
Q2 | $185K | Buy |
+26,292
| New | +$185K | ﹤0.01% | 4879 |
|
|
2020
Q3 | – | Sell |
-7,650
| Closed | -$220K | – | 5153 |
|
|
2020
Q2 | $220K | Buy |
+7,650
| New | +$220K | ﹤0.01% | 3633 |
|